SHIRLEY DUNCAN: Open Payments
NPI 1407323025 · YUCCA VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$341 in 15 payments from 6 companies in 2025. Trend: 2023 $160 · 2024 $36 · 2025 $341
Food & beverage: $341
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $83 |
| Novo Nordisk Inc | 3 | $74 |
| Lilly USA, LLC | 2 | $53 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| ABBVIE INC. | 2 | $45 |
| Amgen Inc. | 2 | $39 |
Products named: XIFAXAN, MOUNJARO, Wegovy, TRELEGY ELLIPTA, QULIPTA, OTEZLA, Rybelsus.
Industry payments across CA — which companies pay providers there.
